Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN FRANCISCO--(BUSINESS WIRE)--BetaStem Therapeutics, Inc., a pre-clinical biotechnology company focused on a curative treatment for diabetic retinopathy and diseases related to vascular damage, has retained Conditas Biotechnology Group, LLC for its services in the area of business development and corporate strategy.
Help employers find you! Check out all the jobs and post your resume.
SAN FRANCISCO--(BUSINESS WIRE)--BetaStem Therapeutics, Inc., a pre-clinical biotechnology company focused on a curative treatment for diabetic retinopathy and diseases related to vascular damage, has retained Conditas Biotechnology Group, LLC for its services in the area of business development and corporate strategy.
Help employers find you! Check out all the jobs and post your resume.
